Advertisement
Screener

Heartflow, Inc. (HTFL) Operating Income

Heartflow, Inc. Operating Income

Heartflow, Inc. (HTFL) reported Operating Income of -$17.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-13

  • Heartflow, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$17.90M.
  • Heartflow, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$29.50M.
  • Heartflow, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$17.75M.
  • Heartflow, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$15.10M.
  • Heartflow, Inc. operating income (loss) for fiscal 2025 was -$64.07M.
  • Heartflow, Inc. operating income (loss) for fiscal 2024 was -$61.22M.
  • Heartflow, Inc. operating income (loss) for fiscal 2023 was -$72.91M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$17.90M
10-Q · filed 2026-08-13
-$47.40M
10-Q · filed 2026-08-13
-$65.15M
derived: sum of 3 quarters · filed 2026-08-13
-$80.25M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$29.50M
10-Q · filed 2026-05-14
-$47.25M
derived: sum of 2 quarters · filed 2026-05-14
-$62.35M
derived: sum of 3 quarters · filed 2026-05-14
-$76.07M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$17.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$32.85M
derived: sum of 2 quarters · filed 2026-03-18
-$46.56M
derived: sum of 3 quarters · filed 2026-08-13
-$64.07M
10-K · filed 2026-03-18
2025-09-30-$15.10M
10-Q · filed 2025-11-12
-$28.81M
derived: sum of 2 quarters · filed 2026-08-13
-$46.32M
10-Q · filed 2025-11-12
-$62.37M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$13.71M
10-Q · filed 2026-08-13
-$31.22M
10-Q · filed 2026-08-13
-$47.27M
derived: sum of 3 quarters · filed 2026-08-13
-$62.20M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$17.50M
10-Q · filed 2026-05-14
-$33.56M
derived: sum of 2 quarters · filed 2026-05-14
-$48.49M
derived: sum of 3 quarters · filed 2026-05-14
-$62.67M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$16.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$30.99M
derived: sum of 2 quarters · filed 2026-03-18
-$45.16M
derived: sum of 3 quarters · filed 2026-03-18
-$61.22M
10-K · filed 2026-03-18
2024-09-30-$14.93M
10-Q · filed 2025-11-12
-$29.11M
derived: sum of 2 quarters · filed 2025-11-12
-$45.16M
10-Q · filed 2025-11-12
2024-06-30-$14.18M
10-Q · filed 2025-09-19
-$30.23M
10-Q · filed 2025-09-19
2023-12-31-$72.91M
10-K · filed 2026-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55